Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Outcome of Patients 65 Years and Older with Myelodysplastic Syndrome (MDS) Receiving Allogeneic Hematopoietic Stem Cell Transplantation Compared to Patients 55-64 Years of Age

Ehab Atallah, MD, Mary M. Horowitz, MD MS, Brent Logan, PhD, Min Chen, MS, Michael J. Boo, JD, Corey S Cutler, MD MPH, Joachim Deeg, MD, James L. Gajewski, MD, Dennis L. Confer, MD, Stephanie Farnia, MPH, Peter Greenberg, MD, Erica Warlick, MD, Daniel Weisdorf, MD, J. Douglas Rizzo, MD

Blood (2015) 126 (23): 193.

https://doi.org/10.1182/blood.V126.23.193.193

Published: 2015

Journal Articles

HLA-Mismatch Is Associated With Worse Outcomes After Unrelated Donor Reduced Intensity Conditioning Hematopoietic Cell Transplantation: A Cibmtr Analysis

John Koreth, MBBS, DPhil, Kwang Woo Ahn, PhD, Joseph Pidala, MD, MS, James L. Gajewski, MD, Hailin Wang, MS, Marcelo A. Fernandez Viña, PhD, D(ABHI), Stephen Spellman, MBS, Stephanie J. Lee, MD, MPH

Blood (2013) 122 (21): 547.

https://doi.org/10.1182/blood.V122.21.547.547

Published: 2013

Journal Articles

Older Age, Use Of Myeloablative Regimens For Malignant Diseases and Chronic Graft-Versus-Host Disease Are Risk Factors For Avascular Necrosis Of Bone After Allogeneic Hematopoietic Cell Transplantation In Children and Adolescents

Xianxin Li, MD, Ruta Brazauskas, PhD, Zhiwei Wang, MS, Amal Al-Seraihy, K. Scott Baker, MD, MS, Jean-Yves Cahn, MD, Haydar A. Frangoul, MD, James L. Gajewski, MD, Gregory A. Hale, MD, Jack W. Hsu, MD, Rammurti T. Kamble, MD, Hillard M. Lazarus, MD, Richard T. Maziarz, MD, Bipin N. Savani, MD, Ami J. Shah, MD, Mohamed L. Sorror, MD, MSc, William A. Wood, MD, MPH, Navneet S. Majhail, MD, MS

Blood (2013) 122 (21): 917.

https://doi.org/10.1182/blood.V122.21.917.917

Published: 2013

Journal Articles

The Role of Hematopoietic Cell Transplantation (HCT) for Burkitt Lymphoma: a Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

James L. Gajewski, MD, Jeanette Carreras, MPH, Hillard M. Lazarus, MD, FACP, Ginna G. Laport, MD, Silvia Montoto, MD, David G. Maloney, Parameswaran Hari, MD

Blood (2010) 116 (21): 2390.

https://doi.org/10.1182/blood.V116.21.2390.2390

Published: 2010

Journal Articles

Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation

Ann E Woolfrey, MD, John Klein, PhD, Michael D Haagenson, MS, Stephen R Spellman, MS, Minoo Battiwalla, MD, James L. Gajewski, MD, Gregory A. Hale, MD, John Horan, MD, MPH, Carolyn K Hurley, PhD, Craig Kollman, PhD, Susana Marino, MD, PhD, Machteld Oudshoorn, PhD, Effie W Petersdorf, MD, Olle Ringdén, MD, PhD, Michelle Setterholm, Stephanie J. Lee, MD, MPH

Blood (2008) 112 (11): 563.

https://doi.org/10.1182/blood.V112.11.563.563

Published: 2008

Journal Articles

A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation

James L. Gajewski, Viviana V. Johnson, S. Gerald Sandler, Antoine Sayegh, Thomas R. Klumpp

Blood (2008) 112 (8): 3036–3047.

https://doi.org/10.1182/blood-2007-10-118372

Published: 2008

Journal Articles

High-Dose Cytoxan, Etoposide, and Cisplatin Followed by Autologous Hematopoietic Cell Transplantation for the Treatment of Hodgkin Lymphoma: A 20-Year Single-Institutional Experience.

Thomas R. Klumpp, MD, Moshe C. Chasky, MD, Robert V. Emmons, MD, Mary E. Martin, MD, James L. Gajewski, MD, Kenneth F. Mangan, MD

Blood (2007) 110 (11): 1913.

https://doi.org/10.1182/blood.V110.11.1913.1913

Published: 2007

Journal Articles

Allogeneic Transplantation after an Alemtuzumab-Containing Myeloablative Conditioning Regimen for CD52 Positive Acute Lymphoblastic Leukemia (ALL).

Partow Kebriaei, MD, Rima M. Saliba, PhD, Carrie Ma, Cindy Ippoliti, PharmD, Daniel R. Couriel, MD, Marcos de Lima, MD, Sergio Giralt, MD, Muzaffar H. Qazilbash, MD, James L. Gajewski, MD, Chul S. Ha, MD, Richard E. Champlin, MD, Issa F. Khouri, MD

Blood (2005) 106 (11): 1135.

https://doi.org/10.1182/blood.V106.11.1135.1135

Published: 2005

Journal Articles

The Impact of Rituximab in the Development of Acute Graft Versus Host Disease (GVHD) Following Allogeneic Stem Cell Transplantation (SCT) for Acute Lymphoblastic Leukemia (ALL).

Partow Kebriaei, MD, Rima M. Saliba, PhD, Carrie Ma, Cindy Ippoliti, PharmD, Daniel R. Couriel, MD, Marcus de Lima, MD, Sergio Giralt, MD, Muzaffar H. Qazilbash, MD, James L. Gajewski, MD, Chul S. Ha, MD, Richard E. Champlin, MD, Issa F. Khouri, MD

Blood (2005) 106 (11): 1803.

https://doi.org/10.1182/blood.V106.11.1803.1803

Published: 2005

Journal Articles

High Doses of CD34+ Cells Chemomobilized with G-CSF PBPC Collection Had Greater CD34(+) Cells Collected Than G-CSF Alone and Trended toward Reduced Progression Rate after Autologous PBPC Transplantation for Breast Cancer in a Phase III Trial.

James L. Gajewski, MD, Rima Saliba, MD, Gabriela Rondon, MD, Naoto T. Ueno, MD, PhD, Michele L. Donato, MD, Paolo Anderlini, MD, Martin Korbling, MD, John D. McMannis, PhD, Sergio A. Giralt, MD, Issa F. Khouri, MD, Rakesh Mehra, MD, Richard E. Champlin, MD

Blood (2004) 104 (11): 5235.

https://doi.org/10.1182/blood.V104.11.5235.5235

Published: 2004

Journal Articles

Allogeneic Transplantation for Adult Acute Lymphoblastic Leukemia (ALL) with Rituximab or Campath I-H.

Issa F. Khouri, MD, Rima M. Saliba, PhD, Partow Kebriaei, MD, Carrie Ma, Cindy Ippoliti, PharmD, Daniel R. Couriel, MD, Marcus de Lima, MD, Sergio Giralt, MD, Muzaffar H. Qazilbash, MD, James L. Gajewski, MD, Richard E. Champlin, MD

Blood (2004) 104 (11): 5132.

https://doi.org/10.1182/blood.V104.11.5132.5132

Published: 2004

Journal Articles

Pilot Study to Test the Efficacy and Safety of Recombinant Factor VIIa (rFVIIa, NovoSeven™) in the Treatment of Refractory Hemorrhagic Cystitis Following High Dose Chemotherapy.

Aneel A. Ashrani, MD, Don A. Gabriel, MD, James L. Gajewski, MD, Nigel S. Key, MD

Blood (2004) 104 (11): 1136.

https://doi.org/10.1182/blood.V104.11.1136.1136

Published: 2004

Journal Articles

A Pilot Study for Haploidentical Transplant Using a Chemotherapy only Preparative Regimen eith T-Cell Depleted Haploidentical Transplant and Intensive Antibiotic Prophylaxis To Treat Advanced Leukemia Patients (pts).

James L. Gajewski, MD, Rima Saliba, PhD, John D. McMannis, PhD, Elizabeth J. Shpall, MD, Cindy Ippoliti, MD, Sergio A. Giralt, MD, Roy B. Jones, MD, Issa F. Khouri, MD, Chitra M. Hosing, MD, Martin J. Korbling, MD, Michele L. Donato, MD, Richard E. Champlin, MD

Blood (2004) 104 (11): 5184.

https://doi.org/10.1182/blood.V104.11.5184.5184

Published: 2004

Journal Articles

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors

Naoto T. Ueno, Yee Chung Cheng, Gabriela Rondón, Nizar M. Tannir, James L. Gajewski, Daniel R. Couriel, Chitra Hosing, Marcos J. de Lima, Paolo Anderlini, Issa F. Khouri, Daniel J. Booser, Gabriel N. Hortobagyi, Lance C. Pagliaro, Eric Jonasch, Sergio A. Giralt, Richard E. Champlin

Blood (2003) 102 (10): 3829–3836.

https://doi.org/10.1182/blood-2003-04-1022

Published: 2003

Journal Articles

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

Raymond Wong, Sergio A. Giralt, Thomas Martin, Daniel R. Couriel, Athanasios Anagnostopoulos, Chitra Hosing, Borje S. Andersson, Pedro Cano, Munir Shahjahan, Cindy Ippoliti, Elihu H. Estey, John McMannis, James L. Gajewski, Richard E. Champlin, Marcos de Lima

Blood (2003) 102 (8): 3052–3059.

https://doi.org/10.1182/blood-2003-03-0855

Published: 2003

Journal Articles

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

Issa F. Khouri, Rima M. Saliba, Sergio A. Giralt, Ming-Sheng Lee, Grace-Julia Okoroji, Fredrick B. Hagemeister, Martin Korbling, Anas Younes, Cindy Ippoliti, James L. Gajewski, Peter McLaughlin, Paolo Anderlini, Michele L. Donato, Fernando F. Cabanillas, Richard E. Champlin

Blood (2001) 98 (13): 3595–3599.

https://doi.org/10.1182/blood.V98.13.3595

Published: 2001

Journal Articles

Use of Leukemic Dendritic Cells for the Generation of Antileukemic Cellular Cytotoxicity Against Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia

Aniruddha Choudhury, James L. Gajewski, Jan C. Liang, Uday Popat, David F. Claxton, Kay-Oliver Kliche, Michael Andreeff, Richard E. Champlin

Blood (1997) 89 (4): 1133–1142.

https://doi.org/10.1182/blood.V89.4.1133

Published: 1997

NARROW

Outcome of Patients 65 Years and Older with Myelodysplastic Syndrome (MDS) Receiving Allogeneic Hematopoietic Stem Cell Transplantation Compared to Patients 55-64 Years of Age

HLA-Mismatch Is Associated With Worse Outcomes After Unrelated Donor Reduced Intensity Conditioning Hematopoietic Cell Transplantation: A Cibmtr Analysis

Older Age, Use Of Myeloablative Regimens For Malignant Diseases and Chronic Graft-Versus-Host Disease Are Risk Factors For Avascular Necrosis Of Bone After Allogeneic Hematopoietic Cell Transplantation In Children and Adolescents

The Role of Hematopoietic Cell Transplantation (HCT) for Burkitt Lymphoma: a Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation

A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation

High-Dose Cytoxan, Etoposide, and Cisplatin Followed by Autologous Hematopoietic Cell Transplantation for the Treatment of Hodgkin Lymphoma: A 20-Year Single-Institutional Experience.

Allogeneic Transplantation after an Alemtuzumab-Containing Myeloablative Conditioning Regimen for CD52 Positive Acute Lymphoblastic Leukemia (ALL).

The Impact of Rituximab in the Development of Acute Graft Versus Host Disease (GVHD) Following Allogeneic Stem Cell Transplantation (SCT) for Acute Lymphoblastic Leukemia (ALL).

High Doses of CD34+ Cells Chemomobilized with G-CSF PBPC Collection Had Greater CD34(+) Cells Collected Than G-CSF Alone and Trended toward Reduced Progression Rate after Autologous PBPC Transplantation for Breast Cancer in a Phase III Trial.

Allogeneic Transplantation for Adult Acute Lymphoblastic Leukemia (ALL) with Rituximab or Campath I-H.

Pilot Study to Test the Efficacy and Safety of Recombinant Factor VIIa (rFVIIa, NovoSeven™) in the Treatment of Refractory Hemorrhagic Cystitis Following High Dose Chemotherapy.

A Pilot Study for Haploidentical Transplant Using a Chemotherapy only Preparative Regimen eith T-Cell Depleted Haploidentical Transplant and Intensive Antibiotic Prophylaxis To Treat Advanced Leukemia Patients (pts).

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

Use of Leukemic Dendritic Cells for the Generation of Antileukemic Cellular Cytotoxicity Against Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only